Information Request Form

Please enter your message in the form below. Your message will be emailed directly to the contact associated with the press release upon the submission of the form.

Press Release:
Active Biotech and Ipsen report for the first time Tasquinimod (TASQ) phase II long term safety data at the 27th European Association of Urology (EAU) Congress
Press Release Date:
02/24/2012 02:45 AM Eastern Time
Your Email Address: (Required)
Subject Line: (Required)
Your Name:
Your Title:
Your Company/Publication Name:
Your Message: (Required)

Information entered into this form will be relayed, solely to the Marketwire client contact that is associated with this release. Your privacy is important to us, and we make sure it is properly protected. Please see our privacy policy for more details.